Nuveen Asset Management, LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 110 filers reported holding AXSOME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$8,262,923
-57.8%
102,645
-58.2%
0.00%
-66.7%
Q1 2024$19,593,054
+4.9%
245,527
+4.6%
0.01%0.0%
Q4 2023$18,675,475
+23.4%
234,646
+8.4%
0.01%
+20.0%
Q3 2023$15,135,169
+108.1%
216,557
+114.0%
0.01%
+66.7%
Q2 2023$7,273,310
+102863.1%
101,215
-11.6%
0.00%0.0%
Q1 2023$7,064
-24.9%
114,522
-6.1%
0.00%
-25.0%
Q4 2022$9,406
-100.0%
121,945
-87.8%
0.00%
-69.2%
Q3 2022$30,959,000
+4.8%
997,324
+29.4%
0.01%
+18.2%
Q2 2022$29,529,000
+109.8%
770,997
+51.4%
0.01%
+120.0%
Q1 2022$14,078,000
-24.6%
509,180
+3.0%
0.01%
-16.7%
Q4 2021$18,671,000
+27.8%
494,206
-25.6%
0.01%
+50.0%
Q3 2021$14,605,000
-67.1%
664,257
+0.9%
0.00%
-69.2%
Q2 2021$44,412,000
+57.3%
658,334
+32.0%
0.01%
+44.4%
Q1 2021$28,239,000
-31.7%
498,750
-1.7%
0.01%
-35.7%
Q4 2020$41,320,000
+9.1%
507,183
-4.6%
0.01%
-6.7%
Q3 2020$37,873,000
+112.0%
531,555
+144.9%
0.02%
+114.3%
Q2 2020$17,863,000
+67.6%
217,089
+19.8%
0.01%
+40.0%
Q1 2020$10,659,000
+1.9%
181,176
+79.1%
0.01%
+25.0%
Q4 2019$10,457,000
+398.9%
101,176
-2.3%
0.00%
+300.0%
Q3 2019$2,096,000
-16.7%
103,559
+6.0%
0.00%0.0%
Q2 2019$2,517,00097,7220.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 991,754$58,345,00037.79%
VR Adviser, LLC 810,000$47,652,00012.91%
ACUTA CAPITAL PARTNERS, LLC 308,500$18,149,0008.80%
Fairmount Funds Management LLC 189,598$11,154,0006.76%
RA Capital Management 1,904,094$112,018,0003.54%
Ghost Tree Capital, LLC 215,000$12,648,0003.36%
MORGAN JESS S & CO INC 42,402$2,495,0003.24%
RTW INVESTMENTS, LP 1,052,969$61,946,0002.67%
EAM Global Investors LLC 50,649$2,980,0001.74%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,172,014$68,950,0001.67%
View complete list of AXSOME THERAPEUTICS INC shareholders